Does Clinical and Biochemical Thyroid Dysfunction Impact on Endometrial Cancer Survival Outcomes? A Prospective Database Study
Endometrial cancer is the commonest gynaecological malignancy in developed countries, and women presenting with high risk or advanced disease have poor outcomes. Thyroid hormones play a key role in cellular metabolism and can influence cancer growth and invasion. Our aim was to evaluate the associat...
Guardado en:
Autores principales: | Chloe E. Barr, Kelechi Njoku, Leo Hotchkies, Neil A. J. Ryan, Y. Louise Wan, David A. Davies, Salman Razvi, Emma J. Crosbie |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bd7b8a1842b044288ec3402154b7e7cc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rate of premalignant and malignant endometrial lesion in “low-risk” premenopausal women with abnormal uterine bleeding undergoing endometrial biopsy
por: Sangam Jha, et al.
Publicado: (2021) -
Prognostic factors determining survival after extrapelvic recurrence in endometrioid type endometrial cancer
por: Fatih Kilic, et al.
Publicado: (2021) -
Identifying a molecular profile to predict the risk of recurrence in high‐intermediate risk endometrial cancer
por: Rebecca C. Arend, et al.
Publicado: (2021) -
An artificial immune system with bootstrap sampling for the diagnosis of recurrent endometrial cancers
por: Chang Chih-Yen, et al.
Publicado: (2021) -
Stage one endometrioid endometrial adenocarcinoma: is there a role of traditional hospital follow-up in the detection of cancer recurrence in women after treatment?
por: Manolis Nikolopoulos, et al.
Publicado: (2021)